Template:ACLS Narrow Regular Tachycardia: Difference between revisions
| Line 4: | Line 4: | ||
*[[SVT]] | *[[SVT]] | ||
**[[Vagal maneuvers]] (convert up to 25%) | **[[Vagal maneuvers]] (convert up to 25%) | ||
**[[Adenosine]] 6mg | **[[Adenosine]] 6mg rapid IV push if patient hemodynamically stable (unstable should proceed directly to electrical cardioversion) | ||
***Can follow with 12mg if initially fails | ***Can follow with repeat dose of 6 mg or 12mg if initially fails | ||
***If [[adenosine]] fails, initiate rate control with | ***If [[adenosine]] fails, initiate rate control with calcium channel blocker or beta blocker or use synchronized cardioversion | ||
****[[Diltiazem]] 15-20mg IV, followed by infusion of 5-15mg/hr | ****[[Diltiazem]] 15-20mg IV, followed by infusion of 5-15mg/hr | ||
****[[Metoprolol]] 5mg IVP x 3 followed by 50mg PO | ****[[Metoprolol]] 5mg IVP x 3 followed by 50mg PO | ||
**Synchronized [[Cardioversion]] (50-100J) | **Synchronized [[Cardioversion]] (50-100J) | ||
***Provide sedation prior to synchronized cardioversion if | ***Provide sedation prior to synchronized cardioversion if patient is hemodynamically stable | ||
Revision as of 20:53, 11 March 2019
Narrow Regular Tachycardia
- Sinus tachycardia
- Treat underlying cause
- SVT
- Vagal maneuvers (convert up to 25%)
- Adenosine 6mg rapid IV push if patient hemodynamically stable (unstable should proceed directly to electrical cardioversion)
- Can follow with repeat dose of 6 mg or 12mg if initially fails
- If adenosine fails, initiate rate control with calcium channel blocker or beta blocker or use synchronized cardioversion
- Diltiazem 15-20mg IV, followed by infusion of 5-15mg/hr
- Metoprolol 5mg IVP x 3 followed by 50mg PO
- Synchronized Cardioversion (50-100J)
- Provide sedation prior to synchronized cardioversion if patient is hemodynamically stable